Lilly and UNICEF Work Together to Help 10 Million Children and Adolescents Have Better Health Outcomes

Published on: 02 February 2022
UNI303943

Lilly's $14.4 million commitment will be used to improve healthcare for children and adolescents who have noncommunicable diseases and those who are at risk of developing them.

Eli Lilly and Company (NYSE: LLY) and UNICEF have today announced a new collaboration to help improve health outcomes for 10 million children and adolescents living with chronic, non-communicable diseases (NCDs) through 2025.

Lilly has committed $14.4 million in support of UNICEF's lifesaving work to address NCD risk factors, strengthen health systems, and enhance the ability of health care workers to care for patients in Bangladesh, Malawi, Nepal, the Philippines and Zimbabwe1. The countries were selected based on the diversity of geography and the potential to strengthen country-level health systems and models that provide care and support for children and adolescents with chronic conditions.

Based on data from the Global Burden of Disease Study, every year nearly one million people under the age of 20 die from often treatable non-communicable diseases, including type 1 diabetes, cancer, congenital and rheumatic heart disease, sickle cell disease and asthma. These deaths account for 15 percent of overall mortality for this age group.

"No child should die from a treatable disease because of inadequate care or treatment. Non-communicable diseases undermine a child's right to health, nutrition, education and play,"

said Karin Hulshof, Deputy Executive Director, UNICEF.

"We are grateful to Lilly for this collaboration to help strengthen health care systems children rely on and ensure health care workers are well-equipped and confident in providing care and treatment to children living with chronic conditions."

This four-year commitment reflects the respective efforts of Lilly and UNICEF to work towards the UN Sustainable Development Goals (SDGs), specifically SDG3, which aims to ensure healthy lives and promote well-being for all at all ages.

"UNICEF's relentless work to reach disadvantaged children, combined with Lilly's experience and deep commitment to bettering people's lives and society, serve as the foundation of this collaborative effort,"

said David A. Ricks, chair and CEO of Lilly.

"This critical, lifesaving work by UNICEF is aligned to the Lilly 30x30 initiative to provide improved access to quality health care for 30 million people in resource-limited settings, annually, by 2030."

Interventions in the five countries will include strengthening data and health information systems for NCDs; establishing and strengthening prevention, care and treatment of NCDs within primary health care and referral facilities (e.g., capacity building of local health care providers including training, mentorship, remote patient monitoring, etc.); and capacity building of service providers for the screening and improved management and treatment of NCDs.

Source: Lilly news

Share:
esg
esg
esg
esg
More from Eli Lilly and Company
Lilly Prices First Sustainability Bond to Advance Global ESG Strategy
Lilly Prices First Sustainability Bond to Advance Global ESG Strategy
Early-Phase Therapies Repurposed to Drive Social Impact
Early-Phase Therapies Repurposed to Drive Social Impact
Creating Sustainable Impact for All Stakeholders: Lilly ESG Updates
Creating Sustainable Impact for All Stakeholders: Lilly ESG Updates